Zhanat Muminova received her M.D. from Kazakh National Medical University named after S.D. Asfendiyarov. She received her Ph.D. in Biomedical Sciences from the Almaty Institute of Epidemiology, Microbiology and Infectious Diseases. She performed her postdoctoral work at the University of Alabama at Birmingham.
1. Research of biomaterials that can mimic the extracellular matrix and allow for appropriate tissue growth and cell differentiation.
2. Applying biomaterials for the development of 3D cellular cultures as an approach to analyze gene function, intracellular signaling and cell phenotype by using various molecular biology techniques and imaging methods.
3. Using 3D cellular cultures for other biomedical applications such as drug screening and delivery along with tissue regeneration.
Muminova Z.E., Strong T.V.and Shaw D.R. Characterization of human mesothelin transcripts in ovarian and pancreatic cancer. BMC Cancer 2004, 4:19;
Shaw D.R., Muminova Z.E., Strong T.V. Mesothelin: a new target for immunotherapy. Clinical Cancer Research, 2004 Dec 15; 10(24):8751;
Thacker E.E., Nakayama M., Smith B.F., Bird R.C., Muminova Z.E., Strong T.V., Timares L., Korokhov N., O’Neill A.M., de Gruijl T.D., Glasgow J.N., Tani K., Curiel D.T. A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo. Vaccine. 2009 Nov 23; 27(50):7116-24.